~~<i id='39F120167B'><strike id='39F120167B'><tt id='39F120167B'><pre id='39F120167B'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

knowledge

entertainment

author：fashion 2025-09-29 22:46:55 - browse：938

A close up photograph of an IV drop in a Portland hospital – politics and policy coverage from STAT — A patient receives an IV drip at a hospital in Portland, Ore. Jenny Kane/AP

WASHINGTON — A new White House task force on drug shortages held a rare in-person meeting last Friday with representatives from hospitals, drugmakers, pharmacies, and others in the drug supply chain to brainstorm policies for stemming shortages of cancer drugs.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： AbbVie buys Immunogen, maker of targeted cancer drugs, for $10B

entertainment

explore

focus

entertainment

knowledge

BiogenrecentlyannounceditwillceaseboththestudyandsaleofitsAlzheimer'sdrugAduhelm.JessicaRinaldi/TheB

WSS

Cano Health’s bankruptcy is a warning for Medicare Advantage

The CDC's new social media misinformation war

Americans' trust in science, scientist continues decline: Report

AbbVie buys Immunogen, maker of targeted cancer drugs, for $10B

Johnson & Johnson sued for allegedly overpaying for workers' drugs

What PEPFAR has meant on the ground in Ukraine

knowledge

entertainment

entertainment

Hepatitis C has a cure — but many Americans still lack access to it

Supreme Court wrestles with OxyContin maker's bankruptcy deal

Anesthesiologist group: stop taking Ozempic before surgery

Why Novartis is going to walk from its acquisition of MorphoSys

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Supreme Court wrestles with OxyContin maker's bankruptcy deal

Alkermes shareholders re

Gene therapy for Afghan refugees’ infant will be fully covered

Novavax promises a turnaround & Lilly roils the obesity market

Why sickle cell disease is getting the first CRISPR treatment

explore

Medicare Advantage plans can’t deny care with AI, CMS warns

Gritstone Bio's cancer vaccine test, and more on Novartis' deal

A single Democrat is willing to weaken Medicare negotiation power

Chemotherapy shortages won’t get better under Biden’s latest plan

Johnson & Johnson sued for allegedly overpaying for workers' drugs

Unique patient identifier: Experts argue the benefits, pitfalls

focus

entertainment

knowledge

knowledge